The Weekly Street Note — W34 · 21 Aug 2026 Premium

Naira Rally and Rate Cuts Draw Two Fresh Conviction Buys

The naira's sharp appreciation to N1,346.90/$ this week, driven by FX turnover that doubled to $4.5 billion, has reset the macro backdrop for Nigerian equities. Simultaneously, headline inflation's retreat to 15.43% in July signals CBN's price stability gains, though the central bank now faces a tougher test in reviving credit and growth. This dual tailwind—currency strength and disinflation—has lifted conviction positioning: FIDSON and MTNN entered Conviction Buy this week, while ARADEL fell out, signaling a meaningful rotation within the model.

The quantitative response is unmistakable. Conviction Buy count stands at nine names this week, with the median investable score holding firm at 67.6/100. The reshuffle reflects the model's sensitivity to margin expansion (naira strength typically lifts importers and manufacturers) and valuation compression in rate-sensitive names like telecoms. HealthCare and Oil & Gas sectors maintain the highest composite scores at 59.7 and 59.4 respectively, anchoring the investable universe.

The forward signal is execution. CBN's growth revival mandate remains nascent—credit growth is the next test—and any stumble in disinflation would reverse the naira's recent momentum. Investors should monitor next week's FX turnover and any CBN forward guidance on rates as the August 25 Eid ul Mawlid holiday approaches, which may thin liquidity.

Three Names Worth Your Attention

MAYBAKER, 92.1/100 composite, stands as the week's flagship conviction buy in HealthCare. The stock commands a disciplined P/E of 11.9x paired with a robust 34.1% ROE and 14.2% net margin, metrics that anchor its 96/100 valuation signal. Daily average volume of ₦546.1M supports institutional accumulation, though the 3.84% spread warrants patience on entry execution.

CWG, 85.3/100 composite, offers a contrarian ICT play grounded in exceptional returns. A 51.0% ROE towers over peers, justified by 9.1x P/E multiple and 6.9% net margin, signaling disciplined leverage and operational efficiency. The 3.56% spread and modest ₦25.1M daily volume suggest this name rewards patient, methodical buying rather than momentum chasing.

ZENITHBANK, 75.1/100 composite, anchors the Financial Services conviction case with unmatched liquidity and profitability. The 4.8x P/E is the tightest in the top three picks, backed by exceptional 43.9% net margin and steady 20.1% ROE, reflecting network scale and deposit franchise strength. Daily turnover of ₦21.30B and a razor-thin 0.08% spread confirm institutional access, though the lower composite score reflects valuation compression already underway.

Movers This Week

Biggest gains — VERITASKAP (+5.7 score delta), UACN (+5.5), and JULI (+5.4) led the week's riser cohort, likely driven by sector momentum in Natural Resources and Agriculture. These moves signal model recognition of currency-tailwind beneficiaries and margin expansion among domestic manufacturers facing naira strength.

Biggest losers — UPL (-8.3 score delta), SUNUASSUR (-7.6), CHAMS (-6.2), NGXGROUP (-6.2), and UCAP (-5.6) posted material composite declines, reflecting valuation resets in insurance and market infrastructure plays where rate sensitivity or macro rerating has triggered model downgrades. These drops warrant sector-level scrutiny rather than individual company news.

Watch list — Monitor CUSTODIAN (+3.9) and WAPIC (+3.6) next week for score momentum follow-through, particularly if HealthCare and insurance sector composite averages stabilise above this week's levels. Both names merit observation as potential early signals of rotation into defensive, yield-proxies as growth revival gains traction.

Full scores, order book data, and sector breakdown on the dashboard.

⚠ Research output only — not personalised investment advice. MoloneyStreetRe Analytics publishes quantitative model scores for research and education purposes. Always carry out your own due diligence before making any investment decision. Capital is at risk.